SCHEMBL619730

SCHEMBL619730

Oc1ccc2ccccc2c1-c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.61
ESR2 Q92731 1/20 0.61
CYP1A2 P05177 4/20 0.59
CYP2C9 P11712 3/20 0.59
CYP2C19 P33261 3/20 0.59
CYP3A4 P08684 2/20 0.59
CYP2D6 P10635 2/20 0.59
HSD17B1 P14061 2/20 0.59
CYP2B6 P20813 2/20 0.59
HSD17B2 P37059 2/20 0.59
PTPN22 Q9Y2R2 1/20 0.56
POLB P06746 1/20 0.52
HSD17B10 Q99714 3/20 0.50
USP2 O75604 1/20 0.50
PAK1 Q13153 1/20 0.50
ALOX5 P09917 1/20 0.50
WDR5 P61964 1/20 0.48
NSD2 O96028 1/20 0.47
OPRM1 P35372 1/20 0.47
OPRD1 P41143 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL10871253 0.98 ESR1 (0.59) ESR1ESR2CYP1A2CYP2C9CYP2C19
SCHEMBL5005580 0.91 HSD17B1 (0.59) ESR1ESR2CYP1A2CYP2C9CYP2C19
SCHEMBL20962174 0.89 ESR1 (0.55) ESR1ESR2CYP1A2CYP2C9CYP2C19
SCHEMBL19547909 0.88 ESR1 (0.67) ESR1ESR2CYP1A2CYP2C9CYP2C19
SCHEMBL29027 0.86 PTPN22 (0.65) CYP1A2CYP2C9CYP2C19PTPN22POLB
SCHEMBL15400598 0.86 PTPN22 (0.65) CYP1A2CYP2C9CYP2C19PTPN22POLB
SCHEMBL29362162 0.86 PTPN22 (0.65) CYP1A2CYP2C9CYP2C19PTPN22POLB
SCHEMBL24804768 0.84 ESR1 (0.50) ESR1ESR2CYP1A2CYP2C9CYP2C19
SCHEMBL7628168 0.84 PTPN22 (0.48) ESR1ESR2CYP1A2CYP2C9CYP2C19
SCHEMBL27656156 0.84 HSD17B1 (0.59) ESR1ESR2CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7588878-B2 Inkless printing paper and method XEROX CORPORATION (US) 2009-09-15 US claimed
US-4533766-A Process for the production of dihydroxybenzenes DEGUSSA AKTIENGESELLSCHAFT (DE) 1985-08-06 US claimed
EP-4737460-A1 CONDENSED HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE AND ELECTRONIC DEVICE Samsung Display Co., Ltd. (KR) 2026-05-06 EP disclosed
US-20260123171-A1 CONDENSED HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE AND ELECTRONIC DEVICE SAMSUNG DISPLAY CO LTD (KR) 2026-04-30 US disclosed
US-12473315-B2 Polycyclic aromatic compound KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2025-11-18 US disclosed
US-20250081847-A1 POLYCYCLIC AROMATIC COMPOUND KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2025-03-06 US disclosed
CN-115650901-B Synthesis method of benzo [ b ] carbazole compound 常州创索新材料科技有限公司 2024-05-31 CN disclosed
US-20230389416-A1 AMINE-CONTAINING COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE INCLUDING THE ELECTRONIC APPARATUS SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-30 US disclosed
US-20230389416-A1 AMINE-CONTAINING COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE INCLUDING THE ELECTRONIC APPARATUS SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-30 US disclosed
US-20230331689-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-19 US disclosed
US-20230331689-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-19 US disclosed
US-20050282225-A1 Quantitative binding assays using green fluorescent protein as a label DAUNERT SYLVIA 2005-12-22 US disclosed
US-20050049306-A1 Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same HARPER DAVID SCOTT (US) 2005-03-03 US disclosed
US-6838583-B2 Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and the methods of using the same WARNER-LAMBERT COMPANY LLC (US) 2005-01-04 US disclosed
EP-1409443-A2 NON-HALOGENATED NAPHTHOL COMPOUNDS, ANTIMICROBIAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME WARNER-LAMBERT COMPANY (US) 2004-04-21 EP disclosed
US-20040010046-A1 Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same MCNEIL-PPC, INC 2004-01-15 US disclosed
US-20020110530-A1 Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same HARPER DAVID SCOTT (US) 2002-08-15 US disclosed
WO-2002050001-A2 NON-HALOGENATED NAPHTHOL COMPOUNDS AND ANTIMICROBIAL COMPOSITIONS CONTAINING THE SAME WARNER-LAMBERT COMPANY (US) 2002-06-27 WO disclosed
EP-0351732-A2 Polyester composition TORAY INDUSTRIES, INC. (JP) 1990-01-24 EP disclosed
US-4286036-A CHARGING THE PHOTOCONDUCTIVE LAYER BELOW THE BREAKDOWN VOLTAGE TO EFFECT A DIELECTRIC CONTACT WITH THE TONER POWDER OCE-NEDERLAND B.V. (NL) 1981-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250081847-A1 POLYCYCLIC AROMATIC COMPOUND PAH, ALK, AOC2 ESR1 105/4885ESR2 264/4885CYP1A2 1566/4885
US-20050049306-A1 Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same NPM1, NOC2L, NAF1 ESR1 1717/4885ESR2 3155/4885CYP1A2 818/4885
US-20260123171-A1 CONDENSED HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE AND ELECTRONIC DEVICE CBR1, C1R, CBR3 ESR1 186/4885ESR2 111/4885CYP1A2 660/4885
US-20040010046-A1 Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same NPM1, NOC2L, NAF1 ESR1 1717/4885ESR2 3155/4885CYP1A2 818/4885
US-12473315-B2 Polycyclic aromatic compound PAH, ALK, AOC2 ESR1 105/4885ESR2 264/4885CYP1A2 1566/4885
US-20020110530-A1 Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same NPM1, NOC2L, NAF1 ESR1 1717/4885ESR2 3155/4885CYP1A2 818/4885
US-20230331689-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, CYP1A1 ESR1 52/4885ESR2 378/4885CYP1A2 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.